Literature DB >> 26200763

Untargeted metabolomics in doping control: detection of new markers of testosterone misuse by ultrahigh performance liquid chromatography coupled to high-resolution mass spectrometry.

Montse Raro1, María Ibáñez1, Rubén Gil1, Andreu Fabregat2, Eva Tudela3, Koen Deventer3, Rosa Ventura2,4, Jordi Segura2,4, Josep Marcos2,4, Aristotelis Kotronoulas2,5, Jesús Joglar5, Magi Farré6, Sheng Yang7, Yanyi Xing7, Peter Van Eenoo6, Elena Pitarch1, Félix Hernández1, Juan Vicente Sancho1, Óscar J Pozo2.   

Abstract

The use of untargeted metabolomics for the discovery of markers is a promising and virtually unexplored tool in the doping control field. Hybrid quadrupole time-of-flight (QTOF) and hybrid quadrupole Orbitrap (Q Exactive) mass spectrometers, coupled to ultrahigh pressure liquid chromatography, are excellent tools for this purpose. In the present work, QTOF and Q Exactive have been used to look for markers for testosterone cypionate misuse by means of untargeted metabolomics. Two different groups of urine samples were analyzed, collected before and after the intramuscular administration of testosterone cypionate. In order to avoid analyte losses in the sample treatment, samples were just 2-fold diluted with water and directly injected into the chromatographic system. Samples were analyzed in both positive and negative ionization modes. Data from both systems were treated under untargeted metabolomic strategies using XCMS application and multivariate analysis. Results from the two mass spectrometers differed in the number of detected features, but both led to the same potential marker for the particular testosterone ester misuse. The in-depth study of the MS and MS/MS behavior of this marker allowed for the establishment of 1-cyclopentenoylglycine as a feasible structure. The putative structure was confirmed by comparison with synthesized material. This potential marker seems to come from the metabolism of the cypionic acid release after hydrolysis of the administered ester. Its suitability for doping control has been evaluated.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200763     DOI: 10.1021/acs.analchem.5b02254

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  5 in total

Review 1.  Metabolomics: A Primer.

Authors:  Xiaojing Liu; Jason W Locasale
Journal:  Trends Biochem Sci       Date:  2017-02-11       Impact factor: 13.807

Review 2.  Applications of Fourier Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap Based High Resolution Mass Spectrometry in Metabolomics and Lipidomics.

Authors:  Manoj Ghaste; Robert Mistrik; Vladimir Shulaev
Journal:  Int J Mol Sci       Date:  2016-05-25       Impact factor: 5.923

3.  Untargeted metabolomics profiles delineate metabolic alterations in mouse plasma during lung carcinoma development using UPLC-QTOF/MS in MSE mode.

Authors:  Huan Wu; Yang Chen; Zegeng Li; Xianhua Liu
Journal:  R Soc Open Sci       Date:  2018-09-19       Impact factor: 2.963

4.  Identification of metabolomic changes in horse plasma after racing by liquid chromatography-high resolution mass spectrometry as a strategy for doping testing.

Authors:  Toshiki Ueda; Teruaki Tozaki; Satoshi Nozawa; Kenji Kinoshita; Hitoshi Gawahara
Journal:  J Equine Sci       Date:  2019-10-02

Review 5.  Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues.

Authors:  Bethany Keen; Adam Cawley; Brian Reedy; Shanlin Fu
Journal:  Drug Test Anal       Date:  2022-03-08       Impact factor: 3.234

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.